EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Comparison of Adverse Event Incidence between Japanese and Non-Japanese: A Systematic Review and Meta-analysis for Patients with Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease, and Atrial Fibrillation/Venous Thromboembolism

Satomi Sakurai, Kazuhiro Matsui, Mamoru Narukawa

Biological and Pharmaceutical Bulletin · 18.11.2026 · 49 (11) · 1884-1893

DOI: 10.1248/bpb.b26-00435 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 18.11.2026. Verfasst von Satomi Sakurai und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhancing diversity in clinical trial populations is increasingly important, particularly for underrepresented populations. We focused on adverse events (AEs) that have been reported to be more frequent in Japanese than in non-Japanese populations and assessed their plausibility. We conducted a systematic review and random-effects meta-analysis of 24 multiregional clinical trials (MRCTs): 9 in rheumatoid arthritis (RA), 11 in chronic obstructive pulmonary disease (COPD), and 4 in atrial fibrillation (AF) or venous thromboembolism (VTE). Pooled estimates of the odds ratios (ORs) compared the incidence of targeted AEs between Japanese and non-Japanese participants using a random-effects model. For Janus kinase inhibitors in RA, the OR for the incidence of herpes zoster was 2.50 (95% confidence interval [CI]: 1.18–5.29, p = 0.0172), suggesting more frequent occurrence in Japanese participants than in non-Japanese participants. The incidence of pneumonia was statistically higher in Japanese in most COPD treatment groups and in the placebo group (OR 4.03 [95% CI: 1.33–12.19, p = 0.0135] for placebo). For direct oral anticoagulants for AF/VTE, the OR for major bleeding was 1.19 (95% CI: 0.91–1.56, p = 0.2105), with no statistically significant difference observed between Japanese and non-Japanese participants. This meta-analysis supported a higher incidence of herpes zoster in Japanese patients with RA, whereas the findings for pneumonia in COPD should be interpreted cautiously, and no statistically significant difference was observed for major bleeding in AF/VTE. Broader inclusion of Japanese participants in MRCTs may improve the interpretability of safety findings and the understanding of population-related differences in drug safety profiles.

Zitieren

APA

Sakurai, S., Matsui, K., & Narukawa, M. (2026). Comparison of Adverse Event Incidence between Japanese and Non-Japanese: A Systematic Review and Meta-analysis for Patients with Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease, and Atrial Fibrillation/Venous Thromboembolism. Biological and Pharmaceutical Bulletin, 49(11), 1884-1893. https://doi.org/10.1248/bpb.b26-00435

Vancouver

Sakurai S, Matsui K, Narukawa M. Comparison of Adverse Event Incidence between Japanese and Non-Japanese: A Systematic Review and Meta-analysis for Patients with Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease, and Atrial Fibrillation/Venous Thromboembolism. Biological and Pharmaceutical Bulletin. 2026;49(11):1884-1893. doi:10.1248/bpb.b26-00435

BibTeX
@article{Sakurai2026,
  author = {Sakurai, Satomi and Matsui, Kazuhiro and Narukawa, Mamoru},
  title = {Comparison of Adverse Event Incidence between Japanese and Non-Japanese: A Systematic Review and Meta-analysis for Patients with Rheumatoid Arthritis, Chronic Obstructive Pulmonary Disease, and Atrial Fibrillation/Venous Thromboembolism},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2026},
  volume = {49},
  number = {11},
  pages = {1884--1893},
  doi = {10.1248/bpb.b26-00435}
}
Kostenlos starten →